Literature DB >> 8950972

p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminus.

J L Byrne1, H F Paterson, C J Marshall.   

Abstract

It has been suggested that a key event in growth factor-induced p21Ras activation by the guanine nucleotide exchange factor Sos, is the recruitment of Sos to the plasma membrane by its interaction with the adaptor protein Grb2. However, other evidence argues that the sub cellular localisation of Sos is independent of Grb2, and that the Sos/Grb2 interaction can be dispensed with for p21Ras activation. To clarify the role of the Sos/Grb2 interaction in ligand-stimulated p21Ras activation, we have utilised the observation that overexpression of the Sos C-terminal domain can effectively inhibit p21Ras-dependent signalling in three different mammalian systems. We have shown that concurrent expression of Grb2, but not SH2 or SH3 domain mutants of Grb2, or the alternative adaptor protein Nck, can rescue this inhibitory effect of the C-terminus. This shows that the Grb2/Sos interaction is required to mediate growth factor-dependent activation of p21Ras, and requires the presence of intact SH2 and SH3 domains of Grb2. This approach was also used for a functional analysis of Sos which revealed that growth factor dependent signals are transmitted through both the N-terminal and C-terminal domains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950972

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Computational docking and solution x-ray scattering predict a membrane-interacting role for the histone domain of the Ras activator son of sevenless.

Authors:  Holger Sondermann; Bhushan Nagar; Dafna Bar-Sagi; John Kuriyan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-02       Impact factor: 11.205

2.  A role for the noncatalytic N terminus in the function of Cdc25, a Saccharomyces cerevisiae Ras-guanine nucleotide exchange factor.

Authors:  R A Chen; T Michaeli; L Van Aelst; R Ballester
Journal:  Genetics       Date:  2000-04       Impact factor: 4.562

3.  Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells.

Authors:  A Denys; A Hichami; B Maume; N A Khan
Journal:  Lipids       Date:  2001-08       Impact factor: 1.880

4.  Signal characteristics of G protein-transactivated EGF receptor.

Authors:  H Daub; C Wallasch; A Lankenau; A Herrlich; A Ullrich
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

5.  N terminus of Sos1 Ras exchange factor: critical roles for the Dbl and pleckstrin homology domains.

Authors:  X Qian; W C Vass; A G Papageorge; P H Anborgh; D R Lowy
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

6.  An activating mutation in sos-1 identifies its Dbl domain as a critical inhibitor of the epidermal growth factor receptor pathway during Caenorhabditis elegans vulval development.

Authors:  Katarzyna Modzelewska; Marc G Elgort; Jingyu Huang; Gregg Jongeward; Amara Lauritzen; Charles H Yoon; Paul W Sternberg; Nadeem Moghal
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

7.  Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives.

Authors:  José M Rojas; José Luis Oliva; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

8.  Regulation of RasGRP via a phorbol ester-responsive C1 domain.

Authors:  C E Tognon; H E Kirk; L A Passmore; I P Whitehead; C J Der; R J Kay
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 9.  Phosphatidic acid signaling regulation of Ras superfamily of small guanosine triphosphatases.

Authors:  Yueqiang Zhang; Guangwei Du
Journal:  Biochim Biophys Acta       Date:  2009-06-21

10.  Signal transduction pathways in chronic inflammatory autoimmune disease: small GTPases.

Authors:  Kris A Reedquist; Paul P Tak
Journal:  Open Rheumatol J       Date:  2012-09-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.